H19 and breast cancer: In a study of quantified levels of the lncRNA, H19 in serum-derived EVs from patients with BC or benign breast disease and healthy subjects, using quantitative real-time PCR, EV H19 expression levels were upregulated in patients with BC compared to that in patients with benign disease and healthy controls.